We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
UK aid is playing a leading role to eradicate polio around the world
The MHRA will review applications for orphan designation at the time of a marketing authorisation (MA) or variation application.
Apply for a promising innovative medicine (PIM) designation or scientific opinion for your medicine from MHRA.
Interim delivery plan outlines 21 actions to improve understanding, research and care for those living with myalgic encephalomyelitis/chronic fatigue syndrome.
Support will target five Neglected Tropical Diseases in 25 of the world’s poorest countries which cause disability and death.
Around three-quarters of the £50 million funding pledged towards cutting edge research into motor neurone disease (MND) has now been handed out to projects across the UK, the government has announced today (Wednesday 21 June).
Advice for medical professionals to follow when assessing drivers with miscellaneous conditions.
Information about the risks of taking valproate medicines during pregnancy.
Thousands of NHS patients could receive faster diagnosis and better treatment for life-changing diseases like cancer, dementia and Parkinson’s.
This study collated and analyzed multiyear cross-sectional data from 9 national schistosomiasis control programmes
Casgevy (exagamglogene autotemcel) is based on the innovative gene-editing tool CRISPR, which won its inventors the Nobel Prize in 2020
The characteristics, symptoms, diagnosis and epidemiology of chikungunya.
This was a observational study, using data collected at all multidrug-resistant-TB treatment centres in Nigeria
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.